重构出处: Amir Goldkorn, Catherine M Tangen, Melissa Plets et al. Baseline circulating tumor cell count as a prognostic marker of PSA response and disease progression in metastatic castrate sensitive prostate cancer (SWOG S1216). Clin Cancer Res. Jan 2021...
原始出处: Amir Goldkorn, Catherine M Tangen, Melissa Plets et al. Baseline circulating tumor cell count as a prognostic marker of PSA response and disease progression in metastatic castrate sensitive prostate cancer (SWOG S1216). Clin Cancer Res. Jan 2021...
Keywords: prostate cancer detection; biomarker; prostate specific antigen (PSA); prostate health index; 4Kscore; PCA3 score; miRNAs; exosomal biomarkers 1. Introduction Prostate cancer (PCa) remains a medical challenge, since it is one of the most frequently diagnosed tumors and a common cause of...
The prostate-specific antigen (PSA) test is used mainly to screen for prostate cancer. Generally speaking, higher PSA levels are associated with a higher risk of prostate cancer, but it's not always the case. Prostate cancer can sometimes occur when PSA levels are lower, while people with ve...
Amir Goldkorn, Catherine M Tangen, Melissa Plets et al. Baseline circulating tumor cell count as a prognostic marker of PSA response and disease progression in metastatic castrate sensitive prostate cancer (SWOG S1216). Clin Cancer Res. Jan 2021...
Amir Goldkorn, Catherine M Tangen, Melissa Plets et al. Baseline circulating tumor cell count as a prognostic marker of PSA response and disease progression in metastatic castrate sensitive prostate cancer (SWOG S1216). Clin Cancer Res. Jan 2021...
Amir Goldkorn, Catherine M Tangen, Melissa Plets et al. Baseline circulating tumor cell count as a prognostic marker of PSA response and disease progression in metastatic castrate sensitive prostate cancer (SWOG S1216). Clin Cancer Res. Jan 2021...
Amir Goldkorn, Catherine M Tangen, Melissa Plets et al. Baseline circulating tumor cell count as a prognostic marker of PSA response and disease progression in metastatic castrate sensitive prostate cancer (SWOG S1216). Clin Cancer Res. Jan 2021...
Amir Goldkorn, Catherine M Tangen, Melissa Plets et al. Baseline circulating tumor cell count as a prognostic marker of PSA response and disease progression in metastatic castrate sensitive prostate cancer (SWOG S1216). Clin Cancer Res. Jan 2021...
In addition to having constant abnormal laboratory (increased C-reactive protein values, leukocyte cell count, serum ferritin, etc.) and clinical (fever) findings, patients' subjective well-being and fulfilled dialysis efficiency remained unchanged during the treatment period; these data induced further...